ASSETMARK, INC - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 254 filers reported holding BALCHEM CORP in Q1 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
ASSETMARK, INC ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$41,181
-8.0%
3320.0%0.00%
Q2 2023$44,757
+6.6%
3320.0%0.00%
Q1 2023$41,991
+3.6%
3320.0%0.00%
Q4 2022$40,541
+1.4%
3320.0%0.00%
Q3 2022$40,000
-7.0%
3320.0%0.00%
Q2 2022$43,000
-23.2%
332
-19.4%
0.00%
Q1 2022$56,000
-18.8%
4120.0%0.00%
Q4 2021$69,000
+9.5%
412
-5.1%
0.00%
Q3 2021$63,000
+10.5%
4340.0%0.00%
Q2 2021$57,000
+5.6%
4340.0%0.00%
Q1 2021$54,000
+8.0%
4340.0%0.00%
Q4 2020$50,000
+19.0%
4340.0%0.00%
Q3 2020$42,000
+2.4%
4340.0%0.00%
Q2 2020$41,000
+7.9%
434
+14.2%
0.00%
Q1 2020$38,000
-2.6%
3800.0%0.00%
Q4 2019$39,000
+2.6%
3800.0%0.00%
Q3 2019$38,0000.0%3800.0%0.00%
Q2 2019$38,000
+8.6%
3800.0%0.00%
Q1 2019$35,000
+16.7%
3800.0%0.00%
Q4 2018$30,000
-36.2%
380
-8.7%
0.00%
Q3 2018$47,000
+14.6%
4160.0%0.00%
Q2 2018$41,000
+20.6%
4160.0%0.00%
Q1 2018$34,0000.0%416
-2.6%
0.00%
Q4 2017$34,0000.0%427
+2.6%
0.00%
Q3 2017$34,000
+6.2%
4160.0%0.00%
Q2 2017$32,000
-5.9%
4160.0%0.00%
Q1 2017$34,000
-2.9%
4160.0%0.00%
-100.0%
Q4 2016$35,000
+9.4%
4160.0%0.00%
Q3 2016$32,000
+28.0%
416
-1.0%
0.00%
Q2 2016$25,000
-3.8%
4200.0%0.00%
Q1 2016$26,0000.0%4200.0%0.00%
Q4 2015$26,0004200.00%
Other shareholders
BALCHEM CORP shareholders Q1 2021
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 436,836$44,396,00037.02%
Brown Capital Management 3,438,569$349,462,0003.34%
Conestoga Capital Advisors, LLC 810,293$82,350,0001.98%
Capital Investment Services of America, Inc. 128,548$13,064,0001.76%
BARD ASSOCIATES INC 31,964$3,249,0001.65%
MOODY ALDRICH PARTNERS LLC 76,261$7,750,0001.59%
Tributary Capital Management, LLC 209,809$21,323,0001.49%
WASATCH ADVISORS LP 1,512,546$153,720,0001.26%
Bath Savings Trust Co 54,485$5,537,0001.00%
SALEM INVESTMENT COUNSELORS INC 117,732$11,965,0000.99%
View complete list of BALCHEM CORP shareholders